220 related articles for article (PubMed ID: 30575933)
1. ICOS/ICOSL upregulation mediates inflammatory response and endothelial dysfunction in type 2 diabetes mellitus.
Zhang HY; Ruan LB; Li Y; Yang TR; Liu WJ; Jiang YX; Li TR; Quan J; Xuan W
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8898-8908. PubMed ID: 30575933
[TBL] [Abstract][Full Text] [Related]
2. ICOS-LICOS interaction is critically involved in TGN1412-mediated T-cell activation.
Weissmüller S; Semmler LY; Kalinke U; Christians S; Müller-Berghaus J; Waibler Z
Blood; 2012 Jun; 119(26):6268-77. PubMed ID: 22577174
[TBL] [Abstract][Full Text] [Related]
3. MiR21 sensitized B-lymphoma cells to ABT-199 via ICOS/ICOSL-mediated interaction of Treg cells with endothelial cells.
Zheng Z; Xu PP; Wang L; Zhao HJ; Weng XQ; Zhong HJ; Qu B; Xiong J; Zhao Y; Wang XF; Janin A; Zhao WL
J Exp Clin Cancer Res; 2017 Jun; 36(1):82. PubMed ID: 28637496
[TBL] [Abstract][Full Text] [Related]
4. Muscle fibres and cultured muscle cells express the B7.1/2-related inducible co-stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathies.
Wiendl H; Mitsdoerffer M; Schneider D; Melms A; Lochmuller H; Hohlfeld R; Weller M
Brain; 2003 May; 126(Pt 5):1026-35. PubMed ID: 12690043
[TBL] [Abstract][Full Text] [Related]
5. Inducible costimulator (ICOS) and ICOS ligand signaling has pivotal roles in skin wound healing via cytokine production.
Maeda S; Fujimoto M; Matsushita T; Hamaguchi Y; Takehara K; Hasegawa M
Am J Pathol; 2011 Nov; 179(5):2360-9. PubMed ID: 21925472
[TBL] [Abstract][Full Text] [Related]
6. ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis.
Alves GF; Stoppa I; Aimaretti E; Monge C; Mastrocola R; Porchietto E; Einaudi G; Collotta D; Bertocchi I; Boggio E; Gigliotti CL; Clemente N; Aragno M; Fernandes D; Cifani C; Thiemermann C; Dianzani C; Dianzani U; Collino M
Front Immunol; 2022; 13():992614. PubMed ID: 36119089
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells regulate type 2 innate lymphoid cells via regulatory T cells through ICOS-ICOSL interaction.
Fan X; Xu ZB; Li CL; Zhang HY; Peng YQ; He BX; Liu XQ; Chen DH; Chen D; Akdis CA; Fu QL
Stem Cells; 2021 Jul; 39(7):975-987. PubMed ID: 33662168
[TBL] [Abstract][Full Text] [Related]
8. Augmented ICOS expression in patients with early diffuse cutaneous systemic sclerosis.
Hasegawa M; Fujimoto M; Matsushita T; Hamaguchi Y; Takehara K
Rheumatology (Oxford); 2013 Feb; 52(2):242-51. PubMed ID: 23024058
[TBL] [Abstract][Full Text] [Related]
9. Inducible T-Cell Costimulator Mediates Lymphocyte/Macrophage Interactions During Liver Repair.
Ramavath NN; Gadipudi LL; Provera A; Gigliotti LC; Boggio E; Bozzola C; Albano E; Dianzani U; Sutti S
Front Immunol; 2021; 12():786680. PubMed ID: 34925367
[TBL] [Abstract][Full Text] [Related]
10. Follicular B Lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL Therapy.
Le KS; Thibult ML; Just-Landi S; Pastor S; Gondois-Rey F; Granjeaud S; Broussais F; Bouabdallah R; Colisson R; Caux C; Ménétrier-Caux C; Leroux D; Xerri L; Olive D
Cancer Res; 2016 Aug; 76(16):4648-60. PubMed ID: 27246829
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide mediated mast cells induce IL-10 producing regulatory T cells through the ICOSL/ICOS axis.
Nie X; Cai G; Zhang W; Wang H; Wu B; Li Q; Shen Q
Clin Immunol; 2012 Mar; 142(3):269-79. PubMed ID: 22154192
[TBL] [Abstract][Full Text] [Related]
12. Deep Flow Cytometry Unveils Distinct Immune Cell Subsets in Inducible T Cell Co-Stimulator Ligand (ICOSL)- and ICOS-Knockout Mice during Experimental Autoimmune Encephalomyelitis.
Raineri D; Abreu H; Vilardo B; Kustrimovic N; Venegoni C; Cappellano G; Chiocchetti A
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473756
[TBL] [Abstract][Full Text] [Related]
13. Th17 down-regulation is involved in reduced progression of schistosomiasis fibrosis in ICOSL KO mice.
Wang B; Liang S; Wang Y; Zhu XQ; Gong W; Zhang HQ; Li Y; Xia CM
PLoS Negl Trop Dis; 2015 Jan; 9(1):e0003434. PubMed ID: 25590646
[TBL] [Abstract][Full Text] [Related]
14. Inducible T-cell co-stimulator (ICOS) and ICOS ligand are novel players in the multiple-myeloma microenvironment.
Boggio E; Gigliotti CL; Moia R; Scotta A; Crespi I; Boggione P; De Paoli L; Deambrogi C; Garzaro M; Vidali M; Chiocchetti A; Stoppa I; Rolla R; Dianzani C; Monge C; Clemente N; Gaidano G; Dianzani U
Br J Haematol; 2022 Mar; 196(6):1369-1380. PubMed ID: 34954822
[TBL] [Abstract][Full Text] [Related]
15. Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis.
Provera A; Ramavath NN; Gadipudi LL; Gigliotti CL; Boggio E; Vecchio C; Stoppa I; Rolla R; Boldorini R; Pirisi M; Smirne C; Albano E; Dianzani U; Sutti S
Front Immunol; 2023; 14():1290391. PubMed ID: 38077334
[TBL] [Abstract][Full Text] [Related]
16. Involvement of inducible costimulator ligand (ICOSL) expression in thyroid tissue in hyperthyroidism of Graves' disease patients.
Wang F; Yan T; Chen L; Chen X; Liu T; Shen S; Li T; Gao L; Wang T; Sun J; Liu C; Wu H; Zhang X; Chen L
J Clin Immunol; 2012 Dec; 32(6):1253-61. PubMed ID: 22706735
[TBL] [Abstract][Full Text] [Related]
17. [Dynamic alteration of CD154/CD40 and its effects on Th1/Th2 polarization in inducible co-stimulator ligand knockout mice infected with Schistosoma japonicum].
Wang Y; Xia CM
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Dec; 47(6):898-904. PubMed ID: 26679647
[TBL] [Abstract][Full Text] [Related]
18. ADAM10-Mediated ICOS Ligand Shedding on B Cells Is Necessary for Proper T Cell ICOS Regulation and T Follicular Helper Responses.
Lownik JC; Luker AJ; Damle SR; Cooley LF; El Sayed R; Hutloff A; Pitzalis C; Martin RK; El Shikh MEM; Conrad DH
J Immunol; 2017 Oct; 199(7):2305-2315. PubMed ID: 28814605
[TBL] [Abstract][Full Text] [Related]
19. CTLA4-Ig-Based Bifunctional Costimulation Inhibitor Blocks CD28 and ICOS Signaling to Prevent T Cell Priming and Effector Function.
Goenka R; Xu Z; Samayoa J; Banach D; Beam C; Bose S; Dooner G; Forsyth CM; Lu X; Medina L; Sadhukhan R; Sielaff B; Sousa S; Tao Q; Touw D; Wu F; Kingsbury GA; Akamatsu Y
J Immunol; 2021 Mar; 206(5):1102-1113. PubMed ID: 33495237
[TBL] [Abstract][Full Text] [Related]
20. Unbalanced expression of membrane-bound and soluble inducible costimulator and programmed cell death 1 in patients with myasthenia gravis.
Yan X; Gu Y; Wang C; Sun S; Wang X; Tian J; Wang M; Ji X; Duan X; Gao H; Fang Q; Dong W; Zhang X; Xue Q
Clin Immunol; 2019 Oct; 207():68-78. PubMed ID: 31374257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
